TITLE

Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis

AUTHOR(S)
Poppius, H.; Salorinne, Y.
PUB. DATE
October 1973
SOURCE
British Medical Journal;10/20/1973, Vol. 4 Issue 5885, p134
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108561

 

Related Articles

  • salbutamol. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p671 

    An encyclopedia entry for the bronchodilator drug "salbutamol" is presented. Salbutamol is usually used in the treatment of asthma, chronic bronchitis, and emphysema, and sometimes given to help prevent premature labour.

  • ipratropium bromide.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1230 

    A definition of the term "ipratropium bromide" which refers to an anticholinergic bronchodilator used for bronchoconstriction associated with chronic bronchitis, chronic obstructive pulmonary disease, emphysema, and asthma is presented.

  • Tudorza Pressair: A Novel Oral Inhalation Therapy for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease- Associated Bronchospasm. Fala, Loretta // American Health & Drug Benefits;Apr2013, Vol. 6 Issue 3, p103 

    The article discusses the Food and Drug Administration (FDA) approval for aclidinium bromide inhalation powder (ABIP) in Tudorza Pressair from Almirall in July 2012 for treating bronchospasm related to chronic obstructive pulmonary disease (COPD), emphysema and bronchitis. Topics include ABIP as...

  • oxitropium bromide.  // Royal Society of Medicine: Medicines;2002, p418 

    This article presents information on oxitropium bromide. Oxitropium bromide is an anticholinergic drug that has the properties of a bronchodilator. It is primarily used to treat chronic bronchitis, but it can also be used as an anti-asthmatic. Administration is by aerosol.

  • Respontin.  // Royal Society of Medicine: Medicines;2002, p473 

    This article presents information on respontin, a proprietary, prescription-only preparation of the anticholinergic and bronchodilator ipratropium bromide. It can be used to treat the symptoms of chronic bronchitis, and is available as a nebulizer solution.

  • Treatment of Chronic Obstructive Pulmonary Disease in Older Patients: A Practical Guide. Yohannes, A.M.; Hardy, C.C. // Drugs & Aging;2003, Vol. 20 Issue 3, p209 

    Chronic obstructive pulmonary disease (COPD) is a common disability, largely encountered in the elderly population, in whom it causes significant morbidity and mortality. The general perception of health professionals is that COPD is often a self-inflicted disorder affecting the more...

  • ipratropium bromide.  // Taber's Cyclopedic Medical Dictionary;2005, p1139 

    A definition of the medical term "ipratropium bromide" is presented. It refers to an anticholinergic bronchodilator used for bronchoconstriction associated with chronic bronchitis, chronic obstructive pulmonary disease, asthma, and emphysema. The definition is from the "Taber's Cyclopedic...

  • Oxivent.  // Royal Society of Medicine: Medicines;2002, p418 

    The article presents information on Oxivent, a proprietary, prescription-only preparation of the anticholinergic drug oxitropium bromide, which also has bronchodilator properties. It can be used to treat chronic bronchitis and some other disorders of the upper respiratory tract. It is available...

  • Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Edwards, Llifon; Perrin, Kyle; Williams, Mathew; Weatherall, Mark; Beasley, Richard // Emergency Medicine Journal;Nov2012, Vol. 29 Issue 11, p894 

    Background The comparative safety of oxygen versus air-driven nebulised bronchodilators in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) is uncertain. A randomised controlled trial was performed to assess the effect on the arterial partial pressure of carbon...

  • Is Combination Therapy with Inhaled Anticholinergics and β2-Adrenoceptor Agonists Justified for Chronic Obstructive Pulmonary Disease? Reddy, Chakravarthy B.; Kanner, Richard E. // Drugs & Aging;2007, Vol. 24 Issue 8, p615 

    Chronic obstructive pulmonary disease (COPD) is a debilitating condition characterised by progressive, irreversible airflow limitation. The economic and social burden of the disease is enormous. The treatment of COPD is guided by the stage of the disease and is aimed primarily at control of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics